Rituxan (rituximab)

pCPA File Number: 20962
Negotiation Status:
Negotiations were not pursued
Indication(s):
Acute Lymphoblastic Leukemia
Sponsor/Manufacturer:
Hoffmann-La Roche
CADTH Project Number:
pCODR 10102
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: